Project Grant R01AI155901
Award Date
3/19/21
Completion Date
2/28/26
Dollars Obligated
$495K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01605, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is supporting research to understand the mechanisms linking cutaneous photosensitivity with systemic autoimmunity in systemic lupus erythematosus (SLE). The $788,508 award to The Hospital for Special Surgery Fund, Inc. will investigate how Langerhans cells regulate dermal lymphatic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $793,093 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Oklahoma Medical Research Foundation to study the regulatory landscape of systemic lupus erythematosus (SLE) with cardiovascular disease (CVD) comorbidity. The research aims to identify the underlying causal variants, target genes, and cell types involved in SLE pathogenesis, with a focus on the impact of SLE and CVD-associated...
This Project Grant award in the amount of $405,350 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support research to characterize lipid droplets in macrophage subsets and determine if manipulating lipid droplet content can shift macrophage function, with the goal of revealing new therapeutic targets for systemic lupus erythematosus (SLE). The...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $715,957 to Northwestern University to conduct research on the mechanisms underlying interferon-induced T peripheral helper (Tph) cell differentiation in systemic lupus erythematosus (SLE). The award, with a period of performance from March 24, 2025 to February 28, 2030, will utilize...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a $173,556 research study at Yale University to investigate the role of retroelements in the autoimmune disease systemic lupus erythematosus (SLE). The 17-month project aims to (1) delineate gene and retroelement expression patterns as well as inflammatory cytokine levels in SLE patient blood and skin samples, (2) identify and characterize...
This Project Grant award of $709,019 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the role of the FOXP3 isoform in the development of systemic lupus erythematosus (SLE). The research aims to determine how the expression of the FOXP3 exon 2 isoform leads to regulatory T cell dysfunction and loss of immune tolerance, resulting in the autoantibody production and other...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), is focused on determining whether a novel splice-modulating oligomer (SMO) can be used to concurrently eradicate pathogenic plasma cells and their precursors in systemic lupus erythematosus (SLE). The $300,000 award, effective from September 18, 2024 to August 31, 2026, will be utilized by the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $256,808 to the University of Washington to investigate the role of dysregulated mRNA splicing in systemic lupus erythematosus (SLE). The research aims to: 1) Expand the analysis of altered mRNA splicing in SLE neutrophils and understand its relationship to disease characteristics, and 2) Explore the consequences of...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Medical University of South Carolina (MUSC) a $365,420 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to study the role of the SLE causal variant NCF1.PR90H in promoting kidney damage. The 2-year project aims to investigate how this genetic variant impacts the function of the NADPH oxidase complex and contributes to systemic lupus erythematosus...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,258,391 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Massachusetts Medical School (UMass Medical) to investigate the roles of RNA splicing factors RAVER1 and PTBP1 in regulating cell death, inflammation, and innate immunity pathways. The research aims to define how these splicing factors control the expression and splicing of the RIPK1 kinase, which serves as a critical...